Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue

Australian Dental Journal

Volumn 55, Issue 4, 2010, Pages 385-389

  Zhou, C X ^a   Gao, Y ^b   Johnson, N W ^a   Gao, J ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

Matrix metalloproteinase 2; matrix metalloproteinase 9; metastasis; oral squamous cell carcinoma; tongue cancer

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CHI SQUARE DISTRIBUTION; ENZYME IMMUNOASSAY; ENZYMOLOGY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; NECK; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NECK; PROGNOSIS; TONGUE NEOPLASMS; YOUNG ADULT;

EID: 78650107988     PISSN: 00450421     EISSN: 18347819     Source Type: Journal    
DOI: 10.1111/j.1834-7819.2010.01258.x     Document Type: Article

References (26)

1. Warnakulasuriya S,. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45: 309-316.
2. Jin WL, Ye WM, Zheng JW, et al., Occult cervical lymph node metastases in 100 consecutive patients with cN0 tongue cancer. Chin Med J (Engl) 2008; 121: 1871-1874.
3. Ferlito A, Silver CE, Rinaldo A,. Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies. Br J Oral Maxillofac Surg 2009; 47: 5-9.
4. Fukano H, Matsuura H, Hasegawa Y, Nakamura S,. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck 1997; 19: 205-210.
5. Chen YW, Yu EH, Wu TH, Lo WL, Li WY, Kao SY,. Histopathological factors affecting nodal metastasis in tongue cancer: analysis of 94 patients in Taiwan. Int J Oral Maxillofac Surg 2008; 37: 912-916.
6. Stöcke W, Grams F, Baumann U, et al., The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 1995; 4: 823-840.
7. Thomas GT, Lewis MP, Speight PM,. Matrix metalloproteinases and oral cancer. Oral Oncol 1999; 35: 227-233.
8. Kurahara S, Shinohara M, Ikebe T, et al., Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999; 21: 627-638. (Pubitemid 29459868)
9. De Vicente JC, Fresno MF, Villalain L, Vega JA, Hernández Vallejo G,. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 2005; 41: 283-293.
10. Sobin LH, Wittekind CH,. The history of the TNM system. In:, Sobin LH, Wittekind CH, eds. TNM Classification of Malignant Tumours. 5th edn. New York: John Wiley and Sons, 1997: 1-4.
11. Johnson NW,. Tobacco use and oral cancer: a global perspective. J Dent Educ 2001; 65: 328-339.
12. Chambers AF, Matrisian LM,. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89: 1260-1270.
13. Gong YL, Xu GM, Huang WD, Chen LB,. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer. J Surg Oncol 2000; 73: 95-99.
14. Li HC, Cao DC, Liu Y, et al., Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma. Breast Cancer Res Treat 2004; 88: 75-85.
15. Chen Y, Zhang W, Geng N, Tian K, Jack Windsor L,. MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus. Head Neck 2008; 30: 1237-1245.
16. Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T,. Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma tissue: immunoreactivity predicts aggressive clinical course. Mod Pathol 2006; 19: 208-217.
17. Christopoulos TA, Papageorgakopoulou N, Ravazoula P, et al., Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma. Oncol Rep 2007; 18: 855-860.
18. Curran S, Murrau GI,. Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis. Eur J Cancer 2000; 36: 1621-1630.
19. Leeman MF, Curran S, Murray GI,. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 2003; 201: 528-534.
20. Yorioka CW, Coletta RD, Alves F, Nishimoto IN, Kowalski LP, Graner E,. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol 2002; 20: 189-194.
21. Dos Reis ST, Pontes J Jr, Villanova FE, et al., Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer. J Urol 2009; 181: 2320-2325.
22. Couillard J, Demers M, Lavoie G, St-Pierre Y,. The role of DNA hypomethylation in the control of stromelysin gene expression. Biochem Biophys Res Commun 2006; 342: 1233-1239.
23. Takagi S, Simizu S, Osada H,. RECK negatively regulates matrix metalloproteinase-9 transcription. Cancer Res 2009; 69: 1502-1508.
24. Luo Y, Liang F, Zhang ZY,. PRL1 promotes cell migration and invasion by increasing MMP-2 and MMP-9 expression through Src and ERK1/2 pathways. Biochemistry 2009; 48: 1838-1846.
25. Yan C, Boyd DD,. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 2007; 211: 19-26.
26. Coussens LM, Fingleton B, Matrisian LM,. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002; 295: 2387-2392.